Navigation Links
UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech
Date:7/17/2008

The world's top engineers, physicians and scientists are joining forces to conceptualize, develop and bring to reality the future tools and treatments of 21st century health care through UC San Diego's new Institute of Engineering in Medicine. Nanoparticle bombs to kill cancer, molecular-sized bridges to repair damaged hearts, and scarless surgery techniques are now on the frontier of medical innovations in California with the new Institute leading the way.

"As is our tradition at UC San Diego, we are bringing together diverse fields of science to catalyze innovation in unconventional ways," said Marye Anne Fox, chancellor of UC San Diego. "The goal of this new organized research unit is to improve health care delivery through new tools, technologies and medicines."

"This is an important step toward the integration of two academic and professional disciplines that increasingly share common goals," said Shu Chien, M.D., Ph.D., professor of bioengineering and medicine, and founding director of the Institute at UC San Diego. "The Institute has already attracted a large number of outstanding faculty from UC San Diego's Schools of Medicine, Pharmacy, and Jacobs School of Engineering who all share the objective of translating creative ideas into clinical medicine and products that will transform patient care."

The Institute of Engineering in Medicine will intersect broad areas of research and focus on new approaches to disease identification, genomic medicine, clinical testing and monitoring, and the discovery of new drugs and therapies. The Institute aligns programs that are rated among the nation's best in U.S. News and World Report's annual "Top Graduate Schools" ranking, with the Jacobs School of Engineering ranked 11th, its bioengineering program ranked 2nd, and the School of Medicine ranked 14th among comparable graduate programs throughout the nation. UC San Diego is one of four universities in the nation with a medical school and
'/>"/>

Contact: Daniel Kane
dbkane@ucsd.edu
858-534-3262
University of California - San Diego
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UC San Diego researchers identify potential new drug candidates to combat bird flu
2. Glowing films developed by UC San Diego chemists reveal traces of explosives
3. UC San Diego researchers eliminate drug discovery bottleneck
4. Biologists at UC San Diego identify key protein in cells self-eating function
5. San Diego Harbor Police Deploy BIO-key(R) Automated Vehicle Location System
6. UC San Diego begins trading greenhouse gas credits on Chicago Climate Exchange
7. Experimental Biology 2008 meets in San Diego April 5-9
8. UC-San Diego Engineering Honor Society wins most outstanding chapter award
9. UC San Diego physicists tackle knotty puzzle
10. NCI grant launches clinical trials for colon cancer screening
11. Queens University launches UKs first Center of Excellence for Public Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Conn. , Aug. 21, 2014 Nxt-ID, ... the growing mobile commerce market, announced today that its ... common stock to be issued in its proposed underwritten ... approved for listing on The Nasdaq Capital Market, subject ... the common stock and warrants, and will trade under ...
(Date:8/21/2014)... study aimed at improving the food intake, health and ... homes is among three projects at the University of ... the Canadian Institutes of Health Research (CIHR). , ... Sciences at Waterloo, and a Schlegel research chair in ... to investigate why many Canadians living in long-term care ...
(Date:8/21/2014)... , Saturday to Wednesday, Oct. 18-22, 2014 , ... W. Harbor Drive, San Diego, CA 92101 , ... and other presentations of the latest research in ... plenary session featuring high-scoring abstracts on rare genetic ... various cancers, and treatment for sun sensitivity (Saturday, ...
Breaking Biology News(10 mins):Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Grants will fund landmark aging research at Waterloo 2American Society of Human Genetics 2014 Annual Meeting 2
... is available in Spanish . , The ... other forms of synaesthesia in which flavours are evoked ... time units, colours by music, etc. Experts on Experimental ... phenomenon. The results of this research have been published ...
... the ravages the disease can take on almost every ... addictive behaviors, even after a period of peaceable abstinence" ... brain active during decision making. "It,s perhaps ... that they have trouble thinking through a decision," said ...
... skates (skates made of animal bones) are the oldest ... BC. Why people started skating on ice and where ... in several locations spread across Central and North Europe. ... Journal of the Linnean Society of London, Dr Formenti ...
Cached Biology News:1 person out of every 1,000 has synaesthesia, in which an individual can smell a sound 21 person out of every 1,000 has synaesthesia, in which an individual can smell a sound 31 person out of every 1,000 has synaesthesia, in which an individual can smell a sound 4Cognitive, genetic clues identified in imaging study of alcohol addiction 2Cognitive, genetic clues identified in imaging study of alcohol addiction 3Cognitive, genetic clues identified in imaging study of alcohol addiction 4
(Date:8/22/2014)... New York (PRWEB) August 22, 2014 ... one of the interesting and challenging endeavors as ... renders highly impervious properties to the foreign substances. ... as possibility of self medication and minimal use ... low molecular weight drugs and provides specific targeting ...
(Date:8/22/2014)... Aug. 22, 2014 Research and Markets ... Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, ... report to their offering. The global ... in 2013, and is expected to grow at a ... Molecular biology enzymes, kits, & reagents find applications in ...
(Date:8/22/2014)... Canada (PRWEB) August 22, 2014 ... in model organisms can be accelerated by exome ... and manufacturing technologies, the custom SeqCap EZ Developer ... research. , Mr. Watson will additionally present how ... with commercially available human and mouse exome kits. ...
(Date:8/21/2014)... MD (PRWEB) August 21, 2014 DNA ... making progress in its development of JRC-LAMP-vax, an innovative ... cedar pollen. Phase IC studies began this month in ... to hay fever. , The Japanese red cedar releases ... people in Japan. Mountain Cedar pollen wreaks similar havoc ...
Breaking Biology Technology:Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3Efficient Identification of Protein-Coding Variants in a Model Organism Through Exome Sequencing, New Webinar Hosted by Xtalks 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4
... and GAITHERSBURG, Maryland, November 2, 2011 ... -based HPV Testing Increases Screening Coverage and is More ... Online in the Lancet Promising findings published ... a community-based, randomized equivalence trial undertaken by public health authorities ...
... announced that data from REMEDEE ( R andomized ... sirolimus coat ED bio- E ngineered ... Combo Bio-engineered Sirolimus Eluting Stent (Combo Dual Therapy Stent), will be ... Session at TCT 2011 in San Francisco. The presentation entitled "REMEDEE: ...
... Pharmaceuticals, Inc. (NASDAQ: OPTR ) today announced ... Credit Suisse Healthcare Conference on Thursday, November 10 at ... (Logo:   http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ) A live ... the Investors page of the Company,s website at ...
Cached Biology Technology:Home-based Self-collected Vaginal Specimens Detect More Cervical Lesions and Cancers Than Cytology 2Home-based Self-collected Vaginal Specimens Detect More Cervical Lesions and Cancers Than Cytology 3Home-based Self-collected Vaginal Specimens Detect More Cervical Lesions and Cancers Than Cytology 4Home-based Self-collected Vaginal Specimens Detect More Cervical Lesions and Cancers Than Cytology 5Data From REMEDEE Trial Featuring OrbusNeich's Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011 2Data From REMEDEE Trial Featuring OrbusNeich's Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011 3
...
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... Recombinant Ribonuclease Inhibitor is a ... ribonucleases such as RNase A. ... Recombinant Ribonuclease Inhibitor is an ... weight ~52 kDa. RNaseOUT inhibits ...
... Inhibitor (Ribonuclease inhibitor) is a ... to inhibit RNase activity. It ... endonuclease activity. , Inhibits ... RNA template , Lacks ...
Biology Products: